Press release
2022 Novo Holdings Seed Investments team Review/Business Update
January 24, 2023Business Services
Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …
Global Company Foot Science International Choose Onyx Health
January 24, 2023Business Services
Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …
Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg
January 24, 2023Business Services
Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
Modus Therapeutics submits patent application for sevuparin in kidney disease
January 23, 2023Business Services
STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)
January 23, 2023Business Services
Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …
NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance
January 19, 2023Business Services
MAIDENHEAD, UK, 19th January 2023 – Alnylam UK Limited, the leading RNA interference (RNAi) therapeutics company, today welcomed a draft …
Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium
January 19, 2023Business Services
PARIS, France, and PRINCETON, N.J., January 19, 2023 – Servier and Taiho Oncology, Inc., today announced the release of data …
NeoPhore completes extension to Series B financing to further advance discovery pipeline
January 19, 2023Business Services
Cambridge, UK, 19 January 2023 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m …
PFIZER EXPANDS ‘AN ACCORD FOR A HEALTHIER WORLD’ PRODUCT OFFERING TO INCLUDE FULL PORTFOLIO FOR GREATER BENEFIT TO 1.2 BILLION PEOPLE IN 45 LOWER-INCOME COUNTRIES
January 18, 2023Business Services
DAVOS, Switzerland, January 17, 2023 – Pfizer Inc.
AstraZeneca UK, Qure.ai and Greater Manchester Cancer Alliance Join Forces to Battle Lung Cancer Waiting Times Using Artificial Intelligence (AI) Technology
January 17, 2023Business Services
London, UK, 13 January 2023 – An initiative to improve earlier diagnosis of lung cancer has been launched by AstraZeneca UK, …
The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations
January 16, 2023Business Services
16 January 2023, Feltham (Merck) – Today Merck, a leading science and technology company, announced that following a resubmission to …
Poolbeg announces strategic expansion of POLB 001 into oncology
January 16, 2023Business Services
16 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …
finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV
January 13, 2023Business Services
London, 9th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised the three …
Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma
January 11, 2023Business Services
London, UK, 11 January 2023 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical …
Ovarian Cancer Commitment launches digital patient support resource for anyone affected by ovarian cancer
January 11, 2023Business Services
28 October 2022, 10:00 BST
Latest content
Dermatology leader Doncker is new Onicor CEO
